The ex vivo maintenance of haematopoietic stem/progenitor cells (HSPCs) is crucial to ensure a sufficient supply of functional cells for research or therapeutic applications. However, when exposed to reactive oxygen species (ROS) in a normoxic microenvironment, HSPCs exhibit genomic instability which may diminish their quantity and quality. This study aimed to investigate the role of N-acetylcysteine (NAC) supplementation on the oxidative stress levels, genotoxicity and lineage commitment potential of murine haematopoietic stem/progenitor cells (HSPCs). Methods: This study was carried out at the Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia, between June 2016 and July 2017. Bone marrow cells were isolated from nine mice and cultured in a growth medium. Various concentrations of NAC between 0.125-2 µM were added to the culture for 48 hours; these cells were then compared to non-supplemented cells harvested from the remaining three mice as the control group. A trypan blue exclusion test was performed to determine cell viability, while intracellular ROS levels and genotoxicity were determined by hydroethidine staining and comet assay, respectively. The lineage commitment potential of erythroid, myeloid and pre-B-lymphoid progenitor cells was evaluated via colony-forming cell assay. Results: NAC supplementation at 0.25, 0.5 and 2 µM significantly increased cell viability (P <0.050), while intracellular ROS levels significantly decreased at 0.25 and 0.5 µM (P <0.050). Moreover, DNA damage was significantly reduced at all NAC concentrations (P <0.050). Finally, the potential lineage commitment of the cells was not significantly affected by NAC supplementation (P >0.050). Conclusion: The findings of this study indicate that NAC supplementation may potentially overcome the therapeutic limitations of ex vivo-maintained HSPCs.
H aematopoietic stem/progenitor cells (HSPCs) constitute a highly promising avenue for medical treatment and research; however, their potency is determined by their ability to selfrenew and differentiate into multiple lineages. 1, 2 Prior to clinical use, stem cells often undergo ex vivo expansion-in which the cells are harvested from an intact organism and directly cultured in a laboratory setting without any biological modification-so as to ensure a sufficient number of functional cells can be harvested. 3, 4 In contrast, in vitro stem cells are obtained from a repository or cell lines that have been genetically transformed.
Physiologically, HSPCs are found in the bone marrow under conditions of low oxygen tension (1-4%). 5, 6 This microenvironment is known as a hypoxic niche and plays a critical role in regulating HSPC expansion and cellular levels of reactive oxygen species (ROS). However, the ex vivo expansion and maintenance of HSPCs requires that the cells adjust to normoxic conditions with greater oxygen tension (21%) and enhanced ROS production. 7 These conditions can interfere with the self-renewal capacities of HSPCs and promote differentiation, leading to premature senescence and therefore fewer functional stem cells for transplantation. 7, 8 Moreover, excessive ROS production can result in genomic instability, thus compromising the quality of the stem cells and limiting their therapeutic potential. 9, 10 Numerous efforts have been made to overcome the limitations associated with the ex vivo expansion and maintenance of HSPCs, including genetic modification, co-culturing with feeder cells and the addition of a cytokine cocktail; however, these approaches have various drawbacks. [11] [12] [13] [14] [15] Recent research has indicated that the use of antioxidants may be a promising ex vivo expansion technique due to their role as excess ROS scavengers. 10, 16, 17 N-acetylcysteine (NAC) is an antioxidant generated from the thiol-containing amino acid cysteine and is the precursor for glutathione. 16, 18 At a concentration of 0.1 µM, NAC supplementation has been reported to preserve the chromosomal stability of cultured HSPCs. 19, 20 Nonetheless, while previous studies have documented the benefits of NAC supplementation in maintaining haematopoiesis, few have examined their use in the ex vivo maintenance of HSPCs or focused on oxidative-mediated cellular damage and lineage commitment. 21, 22 This study therefore aimed to determine the effect of NAC supplementation on the survivability, DNA integrity, cellular ROS levels and lineage commitment potential of ex vivo HSPCs.
Methods
This study was carried out at the Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia, between June 2016 and July 2017. A total of 12 imprinting control region male mice were included in the study, all of which were 10 weeks old and weighed 30-35 g. Bone marrow cells from three mice were each allocated to an experimental group, while bone marrow cells from the remaining three mice constituted the control group. Each experiment to determine cell viability, cellular ROS production and DNA integrity status was repeated in triplicate using 1 × 10 6 cells from a different mouse in each group, while 1 × 10 6 cells were used to determine the lineage commitment potential of erythroid and pre-B lymphoid progenitor cells and 1 × 10 5 cells were used for myeloid progenitor cells.
Each mouse was killed by cervical dislocation and the tibia and femur were isolated. Pre-cooled Gibco ® Dulbecco's Modified Eagle's medium (DMEM; Thermo-Fisher Scientific, Waltham Massachusetts, USA) was flushed over the bones using a 21 gauge needle and a 10 mL syringe. Harvested cells were subsequently filtered through a 40 µM cell strainer, centrifuged at 2,500 rpm for 7 minutes and resuspended in a growth medium consisting of DMEM supplemented with 10% fetal bovine serum and 1% penicillinstreptomycin (ThermoFisher Scientific). A cocktail of growth factors consisting of 100 ng/mL of stem cell factor, 10 ng/mL of interleukin (IL)-6 and 5 ng/mL of IL-3 was then added to the culture (Miltenyi Biotec, Bergisch Gladbach, Germany). Approximately 1 × 10 7 bone marrow cells were obtained from each mouse. 10 The cells were then maintained in a 5% carbon dioxide (CO 2 ) incubator at 37 °C for 24 hours. Subsequently, NAC was added to cells in the experi-Advances in Knowledge -N-acetylcysteine (NAC) supplementation may potentially overcome some of the therapeutic limitations associated with the ex vivo expansion and maintenance of haematopoietic stem/progenitor cells (HSPCs).
-Specifically, NAC supplementation was found to enhance the survivability of murine HSPCs, while also suppressing reactive oxygen species production and DNA damage and maintaining lineage commitment potential. 20 Cells without NAC supplementation were used as the control group for all parameters. However, an additional positive control group was used to analyse DNA damage, for which the cells received 100 µM of hydrogen peroxide for 30 minutes in a 5% CO 2 incubator at 37 °C . A trypan blue exclusion test was performed to quantify the number of viable cells in samples from both the experimental and control groups. The cells were seeded into 24-well plates containing HSPC growth medium at a density of 1 × 10 6 cells/mL. The cell suspension cultures were then diluted at a ratio of 1:1 with 0.4% trypan blue solution, after which the number of viable cells were counted using a microscope. Cellular ROS production was determined as follows. The cells were harvested and centrifuged at 2,500 rpm for 7 minutes. Approximately 1 × 10 6 cells were then resuspended in 1 mL of prewarmed unenriched DMEM medium, stained with 10 mM of hydroethidine (HE; Sigma-Aldrich Corp., St. Louis, Missouri, USA) and incubated in the dark for 30 minutes in a 5% CO 2 incubator at 37 °C . The HE-stained cells were then washed twice and centrifuged at 2,500 rpm for 5 minutes at 4 °C . The supernatant was discarded and the cell pellets resuspended in 500 μL of cold phosphate-buffered saline (PBS). 10 Subsequently, the intensity of HE fluorescence was measured using the BD FACSCanto ™ II flow cytometry system (BD Biosciences, San Jose, California, USA), with ROS production expressed as the percentage of ROS-producing cells.
The potentially genotoxic effect of NAC supplementation was assessed via alkaline comet assay using microgel electrophoresis. 23 This technique was employed due to its improved detection sensitivity in comparison to direct quantification methods which do not supply current or voltage after the unwinding and neutralisation of the DNA. 23, 24 A total of 1 × 10 6 /mL of cells from each group were harvested and centrifuged at 2,500 rpm for 5 minutes at 4 °C . The cells were then washed twice in a calcium-and magnesium-free PBS and recentrifuged at 1,200 rpm for 5 minutes at 4 °C . The cell pellets were mixed with 70 μL of 0.6% normal melting point agarose (NMPA) gel (Sigma-Aldrich Corp.). The mixture was loaded onto a full-frosted microscope slide, topped with a coverslip and left to cool on ice for 15 minutes. Once the gel had solidified, the coverslip was gently removed and a layer of 80 μL of low melting point agarose gel (Sigma-Aldrich Corp.) was added on top of the NMPA layer. Next, the solidified slide was immersed overnight into a lysis buffer consisting of 2.5 M of sodium chloride, 100 mM of disodium ethylenediaminetetraacetic acid, 10 mM of tris(hydroxymethyl)aminomethane and 1% Triton ™ X-100 (Sigma-Aldrich Corp.) at 4 °C . The slides were then equilibrated in an electrophoresis buffer at 300 mA for 20 minutes and then 25 V for 20 minutes, before being rinsed three times in a neutralisation buffer for 5 minutes each rinse. Thereafter, the slides were stained with 25 μL of ethidium bromide (ThermoFisher Scientific) at 20 μg/mL and viewed under a Leica fluorescence microscope (Meyers Instruments, Houston, Texas, USA) using a 590 nm excitation filter. The amount of DNA in the tail and the tail moment of 100 cells per slide was subsequently analysed using CometScore software (TriTek Technologies Inc., Annandale, Virginia, USA).
The lineage commitment potential of the erythroid, myeloid and lymphoid progenitor cells was determined via colony-forming cell assay using three types of methylcelluloses (MethoCult ™ GF M3334, GF M3534 and M3630, STEMCELL ™ Technologies Inc., Vancouver, Canada). These methylcelluloses were used to support the growth of colony-forming unit (CFU)erythroid, CFU-granulocytes (G), CFU-macrophages (M), CFU-GM and CFU-lymphoid (CFU-pre-B) cells. Myeloid progenitor cells were classified as CFU-G, CFU-M or CFU-GM, based on a morphological analysis of the colonies derived from the assay. The plating density was optimised at 2 × 10 5 cells/mL for CFU-GM, 1 × 10 6 cells/mL for CFU-E and 1 × 10 6 cells/mL for CFU-pre-B. The cell and methylcellulose mixture was then placed into a six-well plate and incubated at 37 °C for either seven (for CFU-E and CFU-pre-B) or 14 (for CFU-GM) days. The number of colonies was then determined via light microscope observation.
Statistical analysis was conducted using the Statistical Package for the Social Sciences (SPSS), Version 22.0 (IBM Corp., Armonk, New York, USA). The results were presented as means ± standard error and displayed graphically in the form of histograms or plot diagrams. A P value of <0.050 was considered statistically significant. A Shapiro-Wilk test was conducted to determine the normality of the data. Where the assumption of normality was not rejected, an independent Student's t-test was employed to test the differences in studied parameters between NAC-supplemented and control cell groups.
All procedures involving the use of laboratory animals in this study were reviewed and approved by the Animal Ethics Committee of the Universiti Kebangsaan Malaysia (#FSK/2016/ZARIYANTEY/27-JULY/ 773-JULY-2016-JUNE-2017-AR-CAT2).
Results
In terms of cell viability, there were significantly more viable cells noted among HSPCs supplemented with 0.25 μM (8.47 ± 0.29 × 10 5 cells/mL; P = 0.001), 0.5 μM (8.32 ± 0.72 × 10 5 cells/mL; P = 0.014) and 2 μM (6.37 ± 0.16 × 10 5 cells/mL; P = 0.011) of NAC in comparison to the control group (5.18 ± 0.20 × 10 5 cells/mL) [ Figure 1 ]. Cellular ROS production was also significantly lower among cells supplemented with 0.25 µM (10.23 ± 0.47%; P = 0.011) and 0.5 µM (9.83 ± 1.43%; P = 0.040) of NAC, as compared to the control group (12.20 ± 1.01%) [ Figure 2 ].
Among NAC-supplemented cells, DNA damage was significantly suppressed, with the percentage of DNA in the tail being 7.65 ± 0.40% (P = 0.048), 6.89 ± 0.08% (P = 0.022) and 5.96 ± 0.98% (P = 0.027) for concentrations of 0.25, 0.5 and 2 µM of NAC, respectively, in comparison to the control group (11.08 ± 1.15%) [ Figure 3A ]. In addition, there was also a significant reduction in the tail moment of NAC-supplemented cells at concentrations of 0.25 µM (0.65 ± 0.06 arbitrary units [AUs]; P = 0.002), 0.5 µM (0.71 ± 0.12 AUs; P = 0.003) and 2 µM (0.34 ± 0.03 AUs; P = 0.001), as compared to the control group (2.04 ± 0.10 AUs) [ Figure 3B ].
Regarding the effect of NAC supplementation on the lineage commitment potential of erythroid, lymphoid and myeloid progenitor cells, there was no significant difference in colony count for CFU-GM at 0.25 µM (82.67 ± 11.05 × 10 5 cells/mL; P = 0.075), 0.5 µM (77.00 ± 12.74 × 10 5 cells/mL; P = 0.063) and 2 µM (69.33 ± 18.67 × 10 5 cells/mL; P = 0.072) of NAC supplementation, in comparison to the control group (128.67 ± 15.76 × 10 5 cells/mL). For CFU-G, the control group again demonstrated the highest number of colonies (61.67 ± 7.88 × 10 5 cells/mL); however, this difference was not significant in comparison to cells supplemented with 0.25 µM (36.00 ± 9.64 × 10 5 cells/mL; P = 0.108), Similar results were noted for CFU-M, with the highest colony count identified in the control group (37.00 ± 7.81 × 10 5 cells/mL), followed by cells supplemented with 0.5 µM (30.33 ± 10.41 × 10 5 cells/mL; P = 0.636), 0.25 μM (27.00 ± 6.56 × 10 5 cells/mL; P = 0.382) and 2 µM (23.33 ± 6.44 × 10 5 cells/mL; P = 0.248) and of NAC [ Figure 4A ]. Similarly, no significant differences in CFU-E counts were noted between NAC-supplemented cells at 0.25 µM (84.30 ± 2.91 × 10 6 cells/mL; P = 0.330), 0.5 µM (65.00 ± 14.11 × 10 6 cells/mL; P = 0.177) and 2 µM (68.7 ± 7.84 × 10 6 cells/mL; P = 0.073) and those in the control group (88.30 ± 2.19 × 10 6 cells/mL). The colony counts for CFU-pre-B also showed no significant difference between the control group (47.00 ± 6.08 × 10 6 cells/mL) and the NAC-supplemented cells at concentrations of 0.25 µM (48.00 ± 4.58 × 10 6 cells/mL; P = 0.902), 0.5 µM (42.67 ± 11.05 × 10 5 cells/mL; P = 0.748) and 2 µM (34.00 ± 11.68 × 10 6 cells/mL; P = 0.379) [ Figure 4B ].
Discussion
Maintenance of ROS production at optimum levels is crucial to regulate the intracellular and extracellular signalling pathways involved in the self-renewal and differentiation activities of HSPCs. 5, 25 Excessive levels of ROS can trigger cells to undergo differentiation rather than self-renewal, while too few ROS can inhibit proliferation. 26 The production of ROS is closely related to cellular respiration among metabolically inactive HSPCs in a dormant state. [6] [7] [8] Inversely, when HSPCs are placed under stress, such as in normoxic conditions, mitochondrial activities are elevated and contribute to elevated ROS production. 5, 27 Previous studies have reported that altering the microenvironment of HSPCs to normoxic conditions can lead to a reduction in the number of HSPCs due to an increase in differentiation, premature ageing and apoptosis. 7, 28 In the current study, NAC supplementation was found to enhance the survivability of HSPCs at specific concentrations (0.25, 0.5 and 2 μM). Moreover, HSPCs which did not receive NAC supplementation showed the lowest cell viability. This finding is in accordance with a previous study which reported the beneficial effects of NAC in minimising cytotoxicity among irradiated rat bone marrow cells by improving the mitotic index. 22 Moreover, the current study found that NAC supplementation at concentrations of 0.25 and 0.5 µM suppressed cellular ROS levels; this finding is in agreement with those of a previous study. 5 Altinoz et al. also demonstrated the protective role of NAC against acrylamide-induced oxidative stress in rats. 29 It can therefore be postulated that optimum ROS levels play a role in promoting survivability and maintenance in HSPCs.
Increased ROS production can overload the cellular antioxidant capacity, exposing macromolecules such as DNA, ribonucleic acid and proteins to ROS attack. 30 This can lead to the accumulation of DNA damage and premature cell ageing during long-term culturing. 26 In the present study, NAC supplementation was found to have a genoprotective function, as evidenced by the remarkably low levels of DNA damage observed in NAC-supplemented cells as compared to those in the control group. Other studies have reported that NAC has the ability to reverse DNA damage in rat models with irradiated bone marrow, hepatopulmonary syndrome and acrylamide-induced genotoxicity. 21, 22, 29 The current study also investigated the effects of NAC supplementation on the lineage commitment potential of erythroid, myeloid and lymphoid progenitor cells and found that NAC supplementation did not affect the lineage commitment potential of these respective progenitors. To the best of the authors' knowledge, no previous studies have been conducted to assess the lineage commitment potential among NAC-supplemented ex vivo HSPCs. However, a previous study reported that the administration of 100 µM of NAC for four weeks in mice enhanced the repopulation of myeloid progenitors, as evidenced by increased colony counts. 31 As previously discussed, HSPCs are at greater risk of oxidative stress exposure following ex vivo maintenance, a factor which can impair their usefulness in terms of both quality and quantity. [7] [8] [9] [10] Overall, the results of the present study indicate that NAC may have a potential role as an antioxidant supplement for the optimal expansion and maintenance of HSPCs, without compromising their potential for self-renewal and multilineage differentiation. However, further research is necessary to support these findings, especially considering the small sample size of the current study necessitated by financial constraints and the short study duration. Nevertheless, despite these limitations, these findings may serve as a platform for future research exploring the use of antioxidants in HSPC expansion and maintenance.
Conclusion
The findings of this study support the use of NAC supplementation for the ex vivo maintenance of HSPCs by reducing oxidative stress and maintaining their selfrenewal and multilineage differentiation properties without genotoxic effects. However, further research with a larger sample size is needed to investigate the role of NAC supplementation on the oxidative status and genomic stability of HSPCs following long-term ex vivo maintenance.
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